This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Management of diabetic maculopathy

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • focal maculopathy:
    • photocoagulation is indicated if the visual acuity is better than 6/60
    • vision worse than this usually indicates irreversible damage
  • cystoid maculopathy:
    • treatment is more difficult and less satisfactory than for focal maculopathy
    • strict diabetic control may improve vision
  • ischaemic maculopathy:
    • there is no benefit from photocoagulation
    • close monitoring for pre-proliferative retinopathy is essential

Management principles of diabetic macular oedema:

  • glycaemic and blood pressure control (1)
  • the most common treatment option for diabetic macular oedema is intravitreal injection of antiangiogenic, or anti-vascular endothelial growth
    factor (antiVEGF), drugs, which needs to be repeated over many years (2)
  • other treatments for diabetic retinopathy and its complications, including diabetic macular oedema, are laser photocoagulation, intravitreal steroids, and vitrectomy

Notes:

  • a systematic review concluded that (3):
    • Intravitreal steroids may improve vision in people with DME compared to sham or control...Any benefits should be weighed against IOP elevation, the use of IOP-lowering medication and, in phakic patients, the progression of cataract. The need for glaucoma surgery is also increased, but remains rare.

Reference:

  • Do DV et al. Blood pressure control for diabetic retinopathy. Cochrane Database of Systematic Reviews 2015, Issue 1. Art. No:
    CD006127. [DOI: 10.1002/14651858.CD006127.pub2]
  • Virgil G et al. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis. Cochrane Database of Systematic Reviews 2017, Issue 6. Art. No: CD007419. [DOI: 10.1002/14651858.CD007419.pub5]
  • Rittiphairoj T, Mir TA, Li T, Virgili G. Intravitreal steroids for macular edema in diabetes. Cochrane Database of Systematic Reviews 2020, Issue 11. Art. No.: CD005656. DOI: 10.1002/14651858.CD005656.pub3.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.